Analiza Biaek Finished Product Verified Independent testing of the sealed vial by a leading EU laboratory Sample: Sealed production vial | Order: 100014035 | Tested: April 2026 | Verification Key: H4A29M5E Quanta Pharma 5-Amino-1MQ Specifications 5-Amino-1MQ 50mg by Quanta Pharma Quanta Pharma 5-Amino-1MQ Research Benefits NNMT inhibition : Selectively blocks nicotinamide N-methyltransferase, the enzyme responsible for degrading NAD+ precursors and SAM methyl donors Reduced adipogenesis : Preclinical research demonstrates significant reduction in fat cell formation and white adipose tissue accumulation NAD+ preservation : By inhibiting NNMT, cellular nicotinamide is conserved and available for NAD+ synthesis, supporting mitochondrial function Metabolic regulation : Investigated for effects on insulin sensitivity, glucose metabolism, and cellular energy expenditure Anti-obesity research : Studies in diet-induced obesity models have shown reductions in body weight and adipose mass without affecting food intake Orally bioavailable : As a small molecule rather than a peptide, it maintains activity via oral administration in research protocols, avoiding the need for injection How Quanta Pharma 5-Amino-1MQ Works 5-Amino-1MQ (5-Amino-1-methylquinolinium iodide) is a small molecule selective inhibitor of nicotinamide N-methyltransferase, or NNMT
After two months of twice-daily use, my "11"s are still there, but a little less in your face
The FDA announced a formal advisory committee meeting for this summer to review whether several peptides should be added back to the compounding available list
Black or tarry stool, visible blood in the stool, vomiting blood, severe abdominal pain, unexplained weight loss, persistent fever, anemia, or progressive swallowing difficulty should be evaluated appropriately
Note that this is a convenient form of calculationnot the definition of clearance
